TOP TIERMARKET NEWSWIRE
News & sentiment

FAETH THERAPEUTICS I (FTH) — News & AI sentiment

FAETH THERAPEUTICS I (FTH) news roundup. 6 stories in the past week, 13 over 30 days. Average 30-day sentiment is 55.8/100. No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
6
avg sentiment 52.8/100
30d stories
13
avg sentiment 55.8/100
Insider net (90d)
$0
0 buys · 0 sells
Congress (90d)
0
0 buys · 0 sells

FTH news in the last 24 hours, 7 days, 30 days and 90 days

How much FTH coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowFTH storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days652.8/100FTH headlines →
Last 30 days1355.8/100FTH headlines →
Last 90 days4156.5/100FTH headlines →

Latest stories on FTH

Cantor Fitzgerald reiterates Faeth Therapeutics stock rating
Investing.com Analyst Ratings50 · neutralanalyst
1d ago
1d ago
Faeth Therapeutics, Inc. (FTH) files 8-K
SEC 8-K50 · neutralgeneral
1d ago
1d ago
5d ago
6d ago
Oct 21
William Blair initiates Faeth Therapeutics stock with outperform rating
Investing.com Analyst Ratings63 · neutralanalyst
Oct 16
Oct 16
Oct 15
Oct 8
Citizens maintains Faeth Therapeutics stock rating on PIKTOR data
Investing.com Analyst Ratings50 · neutralanalyst
Oct 7
Oct 6
Sep 18
Faeth Therapeutics, Inc. (FTH) files 8-K
SEC 8-K50 · neutralgeneral
Sep 17
Sep 17
Faeth gets new Buy at Guggenheim on lead asset
Seeking Alpha61 · neutralanalyst
Sep 16
Sep 16
Sep 15
Sep 14
Lucid Capital Markets initiates Faeth Therapeutics stock with buy
Investing.com Analyst Ratings61 · neutralanalyst
Sep 14
TD Cowen initiates Faeth Therapeutics stock with buy rating
Investing.com Analyst Ratings61 · neutralanalyst
Sep 9
Sep 9
Sep 8
Sep 1
Open FTH in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →